drugset / Trial / NCT04032652

Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving Asacol

NCT04032652

Phase 2 Terminated 2 enrolled Endeavor Health
RandomizedCrossoverOpen-labelOther

Summary

The investigators plan to develop a novel method of estimating 5-ASA levels in the rectum at a mucosal level using in vivo rectal dialysis technique towards the eventual goal of determining the optimal dosing of Asacol® that would provide therapeutic levels of 5-ASA in the left colon.

Timeline

Start
2012-12
Primary completion
2014-11
Completion
2014-12-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesalamine Small molecule 1200 mg
Subject Mesalamine Small molecule 2400 mg

Indications